Global X Funds. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Roche Holding AG | 3.21% | $3.36M | 6,099 |
| ELI LILLY AND COMPANYLLY | 3.58% | $2.93M | 2,652 |
| EDWARDS LIFESCIENCES CORPORATIONEW | 3.37% | $2.76M | 31,927 |
| Sandoz Group AG | 2.62% | $2.74M | 25,507 |
| UCB SA | 2.86% | $2.73M | 7,976 |
| ABBVIE INC.ABBV | 3.16% | $2.58M | 11,869 |
| WELLTOWER INC.WELL | 3.07% | $2.51M | 12,218 |
| VENTAS, INC.VTR | 3.06% | $2.51M | 29,677 |
| Alcon AG | 2.35% | $2.46M | 28,830 |
| MERCK & CO., INC.MRK | 2.99% | $2.45M | 20,617 |
| BRISTOL-MYERS SQUIBB COMPANYBMY | 2.98% | $2.44M | 42,594 |
| AMGEN INC.AMGN | 2.93% | $2.40M | 7,123 |
| JOHNSON & JOHNSONJNJ | 2.88% | $2.35M | 10,447 |
| ASTRAZENECA PLC | 2.80% | $2.29M | 12,330 |
| STRYKER CORPORATIONSYK | 2.78% | $2.28M | 7,469 |
| MEDTRONIC PUBLIC LIMITED COMPANYMDT | 2.60% | $2.13M | 28,814 |
| REGENERON PHARMACEUTICALS, INC.REGN | 2.48% | $2.03M | 3,299 |
| BOSTON SCIENTIFIC CORPORATIONBSX | 2.44% | $2.00M | 41,335 |
| BeOne Medicines AGONC | 2.24% | $1.83M | 6,362 |
| DEXCOM, INC.DXCM | 2.01% | $1.65M | 22,316 |
| Straumann Holding AG | 1.37% | $1.43M | 9,223 |
| UNITED THERAPEUTICS CORPORATIONUTHR | 1.73% | $1.41M | 2,537 |
| Sonova Holding AG | 1.12% | $1.18M | 3,457 |
| INCYTE CORPORATIONINCY | 1.36% | $1.11M | 11,515 |
| SMITH & NEPHEW PLC | 0.90% | $995.43K | 49,312 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH | 1.14% | $929.59K | 11,291 |
| NEUROCRINE BIOSCIENCES, INC.NBIX | 1.12% | $916.87K | 5,792 |
| Fresenius Medical Care AG | 0.90% | $857.62K | 16,934 |
| OMEGA HEALTHCARE INVESTORS, INC.OHI | 0.97% | $797.59K | 17,057 |
| EXELIXIS, INC.EXEL | 0.92% | $756.59K | 14,988 |
| DAVITA INC.DVA | 0.92% | $749.26K | 3,855 |
| INSULET CORPORATIONPODD | 0.72% | $591.65K | 4,082 |
| THE ENSIGN GROUP, INC.ENSG | 0.69% | $562.30K | 3,354 |
| NOVO NORDISK A/S | 3.80% | $484.91K | 67,891 |
| AEDIFICA NV | 0.49% | $464.43K | 4,817 |
| HALOZYME THERAPEUTICS, INC.HALO | 0.56% | $455.33K | 6,843 |
| Ypsomed Holding AG | 0.43% | $452.27K | 788 |
| NOVOCURE LIMITED | 0.48% | $392.40K | 23,028 |
| MANNKIND CORPORATIONMNKD | 0.46% | $373.03K | 98,947 |
| GLAUKOS CORPORATIONGKOS | 0.43% | $348.08K | 3,368 |
| AMPLIFON S.P.A. | 0.36% | $340.94K | 23,225 |
| TELEFLEX INCORPORATEDTFX | 0.40% | $328.16K | 2,551 |
| CLARIANE SE | 0.34% | $328.12K | 57,561 |
| Pharma Mar, S.A. | 0.33% | $319.07K | 2,343 |
| EMEIS SA | 0.33% | $317.81K | 15,663 |
| Medacta Group SA | 0.30% | $313.61K | 1,337 |
| CG Oncology IncCGON | 0.37% | $303.54K | 4,873 |
| LIVANOVA PLCLIVN | 0.36% | $294.98K | 3,997 |
| SABRA HEALTH CARE REIT, INC.SBRA | 0.35% | $289.42K | 14,551 |
| SONIDA SENIOR LIVING, INC.SNDA | 0.33% | $274.07K | 7,753 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.